Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis.
- DOI
- 10.1002/cam4.2960
- Published
- 2020-03-05
- Container
- Cancer Med
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cam4.2960,
title = {Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis.},
author = {White-Gilbertson S and Lu P and Jones CM and Chiodini S and Hurley D and Das A and Delaney JR and Norris JS and Voelkel-Johnson C.},
year = {2020},
journal = {Cancer Med},
doi = {10.1002/cam4.2960},
url = {https://doi.org/10.1002/cam4.2960}
}RIS
TY - JOUR TI - Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis. AU - White-Gilbertson S AU - Lu P AU - Jones CM AU - Chiodini S AU - Hurley D AU - Das A AU - Delaney JR AU - Norris JS AU - Voelkel-Johnson C. PY - 2020 JO - Cancer Med DO - 10.1002/cam4.2960 UR - https://doi.org/10.1002/cam4.2960 ER -
APA
S, W., P, L., CM, J., S, C., D, H., A, D., JR, D., JS, N., & C., V. (2020). Tamoxifen is a candidate first-in-class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells-Unrecognized players in tumorigenesis.. Cancer Med. https://doi.org/10.1002/cam4.2960
Source records
- europe-pmc · retrieved 2026-09-26T13:23:04.679Z